Microbial membrane and biofilm

Microbial membranes and biofilms are fundamental structural targets in anti-infective therapy. The microbial membrane, consisting of lipid bilayers and associated proteins, maintains cellular integrity and regulates essential physiological processes such as ion transport and energy transduction (StatPearls, 2023). Biofilms are complex, multicellular communities of microorganisms embedded within a self-produced matrix of extracellular polymeric substances (EPS), which includes polysaccharides, proteins, and extracellular DNA (NIH, 2002). These structures play a pivotal role in pathogenesis by protecting microbes from host immune responses and increasing their tolerance to antimicrobial agents by up to 1,000-fold compared to planktonic cells (Nature Reviews Microbiology, 2004). Therapeutic intervention involves disrupting membrane stability using agents like polymyxins or daptomycin, or targeting the biofilm matrix to enhance drug penetration and facilitate microbial clearance (PubMed, 2017). Understanding the interplay between membrane integrity and biofilm architecture is essential for developing next-generation antimicrobials capable of overcoming multi-drug resistance (NCBI, 2021).

Other names

Bacterial cell envelopeFungal cell membraneExtracellular polymeric substanceEPS matrixSessile microbial communityMicrobial lipid bilayer

Drugs targeting microbial membranes typically act through pore formation, disruption of lipid bilayers, or binding to specific components like lipopolysaccharides (LPS) or ergosterol to cause cytoplasmic leakage and cell death. Biofilm-targeted agents focus on degrading the extracellular polymeric substance matrix, inhibiting initial attachment, or disrupting quorum sensing pathways to restore antibiotic sensitivity and facilitate clearance by the immune system.